ShareValue scores for ALBERTDAVD.NSE: Valuation 70, Quality 35, Growth 21, Health 52.
ALBERTDAVD.NSENSE
Albert David Limited
₹737.50
(+6.45%)
ALBERTDAVD.NSENSE
Albert David Limited
₹737.50(+6.45%)
Loading chart...
Sentiment
Verdicts
Value:Undervalued
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
12% to 27%
Rating
Trap Risk
Return
12% to 27%
Valuation
70
Undervalued
Price vs Value
Quality
35
Weak
Business Strength
Growth
21
Weak
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
48
Neutral
Price Trend
Company Details
About
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Market Cap$4.21B
P/E Ratio42.2
Dividend YieldNone
Sector Rank#2493
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026